Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients

Author(s):  Schotik Debora

Issue:  Jan/Feb 2001 - Compounding for Pediatric Patients
View All Articles in Issue

Page(s):  9-12

Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Page 1
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Page 2
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Page 3
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Page 4

Download in electronic PDF format for $65

Abstract:  More than 80% of prescription drugs approved by the US Food and Drug Administration for human use are not approved for use in the pediatric population. When there is not a commercially available dosage form for pediatric use, it is the pharmacist’s responsibility to compound a stable and acceptable formula in accordance with good pharmacy practices, official standards and relevant scientific data. The author discusses the stability of formulations; factors affecting stability; types of oral liquids; beyond-use dating; flavors, taste and coloring; issues for administration of medications to children and stability studies (information sources, the pharmacist and the literature and US Food and Drug Administration updates).

Related Keywords: beyond-use date, children, coloring, emulsions, flavors, infants, oral formulations, oral liquids, pediatric, pediatric administration, solutions, stability, suspensions, taste, Loyd V. Allen, Jr., PhD, RPh, continuing education, quality control, endotoxins, pyrogens, gram-negative bacteria, lipopolysaccharide, endotoxin limit, endotoxin load, sterile preparations, standards, USP

Related Categories: PEDIATRICS, STABILITIES, COMPATIBILITIES, UNITED STATES PHARMACOPEIA CONVENTIONS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Schotik Debora
Jan/Feb 2001
Pg. 9-12

Pediatric Compounding: Coloring Outside the Lines
Preckshot John
Jan/Feb 2001
Pg. 6-8

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design
Patel Gopesh
, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
Jan/Feb 2021
Pg. 73-81

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved
Allen Loyd V Jr
Sep/Oct 2021
Pg. 396-400

Pediatric Dermatitis
Remmert Renee
Nov/Dec 2002
Pg. 419-421

Featured Excipient: Flavor Enhancing Agents
Allen Loyd V Jr
Jan/Feb 2003
Pg. 48-50

Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children
Nahata Milap C
May/Jun 2016
Pg. 247-249

Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations
Cooper James F
Jan/Feb 2011
Pg. 49-54

Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Fonseca Simonne C
Nov/Dec 2005
Pg. 456-461